Target intelligence / Profile preview

Human cytomegalovirus immediate-early protein 2 (IE2)

Target
IE2
Molecular classification
Transcription factor (viral), Regulator of viral gene expression, DNA-binding protein, Viral regulatory protein
01

Overview

Human cytomegalovirus immediate-early protein 2 (IE2) is a multifunctional viral transcription factor encoded by the UL122 locus of the HCMV genome. It is expressed early after infection as three major isoforms (p86, p60, p40). IE2 directly binds viral DNA, activates and represses viral gene transcription—including autoregulation of the immediate-early promoter—and is essential for progression of the viral lytic cycle. IE2 orchestrates the formation of viral replication compartments in the host cell nucleus and interacts dynamically with host transcription factors (TBP, TFIIB, and chromatin modifiers). Beyond its viral regulatory activities, IE2 modulates host cell signaling, promotes G1/S cell cycle transition, and arrests S phase progression, preventing host DNA replication while favoring viral replication. IE2 also antagonizes host immune signaling by downregulating interferon-β and inflammatory chemokine responses. These diverse regulatory actions make IE2 a key determinant of HCMV infection, pathogenesis, and persistence.

Other names
Immediate-early protein 2 (IE2)UL122 (HCMV genome locus)86 kDa immediate-early protein 2 (isoform p86)60 kDa immediate-early protein 2 (isoform p60)40 kDa immediate-early protein 2 (isoform p40)
02

Mechanism of action

Not directly applicable; hypothetical or experimental drugs would act by: - Inhibiting IE2-DNA binding - Blocking IE2-mediated transcriptional regulation - Interfering with protein-protein interactions between IE2 and host or viral factors

03

Biological functions

Transcriptional activation and repression of viral genesAutoregulation (negative feedback on its own promoter)Cell cycle arrest and modulationInteraction with host transcription machinery (e.g., TBP, TFIIB, TAF4, UL84)Antagonism of immune signaling pathways (e.g., downregulation of interferon-β and chemokines)Formation of viral replication compartments in the nucleus
04

Disease associations

Infection (required for lytic replication of human cytomegalovirus)Possible involvement in cognitive disorders linked to viral gene regulation in host tissue
05

Safety considerations

IE2 is essential for HCMV replication; targeting it may risk off-target effects on host transcription machinery due to its extensive interactions with cellular factors.HCMV latency in host cells and the robust viral replication cycle present challenges for drug access and efficacy.Host immune suppression and viral escape can complicate therapeutic targeting.
06

Biomarkers

No established patient selection or efficacy biomarkers are directly related to IE2. IE2 gene or protein expression may serve as a marker of active HCMV replication in research or diagnostic settings.

Beyond the preview

Go deeper on Human cytomegalovirus immediate-early protein 2 (IE2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human cytomegalovirus immediate-early protein 2 (IE2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call